Sugi Holdings Co.Ltd (SGIPF) fair value: what the stock is really worth
As of Oct 30, 2026: fair value (intrinsic value) of Sugi Holdings Co.Ltd stock $18.06, price $8.09, upside +123.2%, quality 71 out of 100. Rating: strongly undervalued. Calculated from audited financials with 26 valuation models and 37 quality factors, updated daily.
Keep an eye on it?Free in your watchlist: 5 stocks without an account, 10 with oneYes, for free
69 individual criteria per stock, every one traceableSee the method →
Price vs Fair Value
White line = price, green steps = our fair value per fiscal year. As of Nov 4, 2026.
How to read this chart
60‑month range $6.73 – $633,711 · fair‑value band $12.64 – $23.48 · the $8.09 price screens below the $18.06 fair value. Green steps = our fair value per fiscal year (point-in-time, no hindsight). As of Nov 4, 2026.
Follow Sugi Holdings Co.Ltd in your weekly email
Every Wednesday you see whether Sugi Holdings Co.Ltd is on track or worth a review, plus price against fair value. Free, up to 3 stocks.
We send you a confirmation link. Unsubscribe with one click.
Sugi Holdings Co.,Ltd. operates drugstores in Japan.
Show moreShow less
The company also provides self-care support services, including meal delivery, cancer and other health checkups, specific health guidance, health information, and community comprehensive agreements; health care support, such as medicine support, home-visit dispensing and nursing, prevention programs, shopping assistance, and mobility support services.
In addition, it engages in drugstore operation, dispensing pharmacy operation, medical consultation, business in foreign countries, Chinese medicine pharmacy operations, disease prevention and health support, promotion of disabled employment, home visit nursing and elderly home-care support, support for commencement of medical practice, comprehensive staff agency service, and support business for pharmacy operations.
Sugi Holdings Co.,Ltd. was founded in 1976 and is headquartered in Obu, Japan.
Stock analysis
Sugi Holdings Co.Ltd (SGIPF) currently trades at $8.09, while our model-based Fair Value estimate is $18.06, implying the stock looks roughly 55% undervalued today.
Show more
Valuation
Bull case: the DCF Models group reads highest at a median of $24.91 per share, and 22 of the 26 models we run sit above the $8.09 price.
Bear case: the Dividend Discount group reads lowest at $1.86, and 4 of the 26 models stay below the price. Data coverage for this calculation is high.
Scenario range: $12.64 (bear) to $23.48 (bull), the price of $8.09 sits below it. Bear and bull are the same models on cautious and optimistic assumptions, a range, not a price target.
Quality & growth
The Quality Score stands at 71/100 (solid quality), in the Healthcare sector.
Healthy Growth: Revenue growth appears healthy and is supported by profitability and cash-flow quality.
Sugi Holdings Co.Ltd reported revenue of ¥1.0T in FY2026 versus ¥744B in FY2024, a compound +16.7%/yr. Reported net income was ¥45.1B in FY2026, compounding +43.3%/yr from FY2024.
Key figures
Market cap $3.0B Mid · P/E ratio 15.6 · P/S ratio 0.69 · EPS (TTM) $0.5200 · Dividend yield 1.4% · Net margin 4.5% · Return on equity 9.9% · Return on assets (EBIT) 8.6%.
Competitive moat
Our AI-assisted moat analysis scores the competitive advantage at 36 out of 100 (low confidence).
What moves the price
The share trades about 15% below its 52-week high and 7% above its 52-week low, currently below its 200-day average.
For context, the median of 10 Healthcare peers we cover trades at 25% fair-value upside, at 123%, SGIPF screens cheaper than that median.
Fair Value models
Bear$12.64Fair Value $18.06Bull$23.48
Price $8.09 · Upside +123.2%
Model ⓘEach model values the company its own way (discounted cash flow, earnings, assets, dividends). The fair value above starts from their evidence-weighted blend, not from a single model. In cyclical trough or peak years, after dilution or a stock split it is adjusted afterwards, so it can sit above or below the models. Based on fiscal year 2026 figures (about 8 months old). Earnings retained since then ($0.2803 per share) are deliberately not added.Bear ⓘBear = the cautious scenario: the same model computed with conservative anchors (lower growth, margins and valuation multiples). Together with Bull it frames a plausible valuation range, not a price target.BaseBull ⓘBull = the optimistic scenario: the same model computed with favourable anchors (higher growth, margins and valuation multiples). Together with Bear it frames a plausible valuation range, not a price target. If a model's bull case is above four times its base value, the table shows that limit with a > sign (like the overall Bull above): beyond it no assumption holds.Coverage ⓘCoverage = how well-backed THIS model's estimate is for this stock (0–100): how complete and reliable its input data are, and how well the model fits the company. The final Fair Value is an evidence-weighted blend, so better-evidenced models count more. Green ≥70, amber 50–69, grey below 50.
Growth Quality ⓘGrowth is valuable only when reinvestment earns attractive returns (Aswath Damodaran): sustainable growth depends on return on capital, reinvestment and efficiency. Basis: total company revenue over the periods shown on the cards (3Y/5Y/all years), not per share, so a merger can show up as a growth jump; per-share earnings growth is in the value-creation card.85/100
Revenue growth appears healthy and is supported by profitability and cash-flow quality.
What shareholders gained per year ⓘWe only publish this rate when it is defensible. Reason: only 3 usable fiscal years, at least 4 required
not computed
Growth Forecast
Little optimism in the price
The price assumes less growth than the company has delivered so far and less than analysts expect.
What the price assumes ⓘThis turns our valuation around: instead of asking what the share is worth, it asks what growth the current price requires. It uses the cash the company keeps after all spending (free cash flow), the same discount rate as our models, five years of growth, then slowing evenly to 2 % a year by year ten. Compared with the analysts' sales forecasts extended to the same five years (at least three analysts, for context only, it does not enter the Fair Value): within 3 percentage points counts as "in line" (amber), below that little optimism (green), above that a lot of optimism (red).
−24.8%
The company could shrink this much every year for the next five years and today's price would still be justified.
What forecasts expect ⓘAnalysts publish sales forecasts for the next two fiscal years. For the years after that, growth slows evenly to 2 % a year by year ten (2 % is the long-run rate our models use). Projected years are marked as such.
+8.4%
Yearly sales growth analysts expect, extended to five years.
After inflation (figures in JPY, Japan: IMF forecast 2.1% a year to 2030, 1.3% from 2016 to 2025) that is about −26.4% a year for the price and +6.1% for the forecasts.
News mood ⓘNews mood, the average tone of recent news (3 articles), rated against how stocks are usually covered. 🚀 Hype = unusually upbeat · 🙂 Positive = above average · 😐 Neutral = typical · 🙁 Negative = below average · 😨 Very negative = unusually downbeat. It reflects the tone of coverage, not our valuation.Hype
Recent news coverage is unusually upbeat, far more positive than stocks are typically covered.
Price, fair value, quality and upside side by side.
Free, no sign-up
Peer GroupⓘHow this stock ranks against its industry: the green marker is this stock, the band is the typical 25–75% peer range, and the tick is the median.Pharmaceutical Retailers · 50 stocks
Beats the industry median on 12/14 measures
Overall it ranks above its industry peers.
Valuation
Quality Score71 · Top 25%
Fair Value upside+123.2% · Top 25%
Profitability
Return on equity (12 months)9.9% · Above median
Return on assets7.3% · Top 25%
Net margin (12 months)2.8% · Above median
Operating margin (12 months)4.6% · Above median
Growth and dividend
Revenue growth (quarter YoY)6.2% · Above median
Dividend yield (12 months)1.4% · Below median
Balance sheet
Debt / equity0.23× · Above median
Valuation Multiplesvs Pharmaceutical Retailers median · lower = cheaper
For bloggers, editors and developers: paste this into your site or blog (a “Custom HTML” block in WordPress), it shows the current fair value and links back here. Free, plain HTML, and welcome. Full data streams (CSV/JSON) at /developers.
Is Sugi Holdings Co.Ltd (SGIPF) overvalued or undervalued?
As of Nov 4, 2026, our model estimates a fair value of $18.06 versus a price of $8.09, about +123% upside (undervalued).
What is the fair value of SGIPF?
Our model-based fair value for Sugi Holdings Co.Ltd is $18.06 (as of Nov 4, 2026), built from audited fundamentals. The current price: $8.09.
What is the quality score of SGIPF?
Sugi Holdings Co.Ltd has a Quality Score of 71/100. It measures business quality (profitability, growth, cash flow, balance-sheet strength, investment discipline, share issuance). Market factors such as price momentum and volatility do not enter the number; they are shown separately in the detail view.
What is the price target for Sugi Holdings Co.Ltd (SGIPF)?
Our model-based price target is the fair value of $18.06 (as of Nov 4, 2026) from 26 valuation models. Cautious scenario $12.64, optimistic scenario $23.48. It is a calculation from audited fundamentals, not an analyst target.
What is the Sugi Holdings Co.Ltd stock forecast for 2026?
Our models put fair value at $18.06, about +123% upside versus a price of $8.09 (undervalued). Cautious scenario $12.64, optimistic scenario $23.48. The calculation is refreshed regularly with new filings.
What is the revenue of Sugi Holdings Co.Ltd (SGIPF)?
Sugi Holdings Co.Ltd reported trailing-twelve-month revenue of about ¥1.1T (latest available figure, as of Nov 4, 2026).
Does Sugi Holdings Co.Ltd pay a dividend?
Sugi Holdings Co.Ltd currently shows a dividend yield of 1.37% relative to its recent price (as of Nov 4, 2026).
What growth is priced into Sugi Holdings Co.Ltd (SGIPF)?
For today's price to be fair in a discounted-cash-flow model, Sugi Holdings Co.Ltd would have to grow free cash flow by -24.8 % per year for five years (discount rate 8.5 %, then slowing evenly to 2 % perpetual growth by year ten). Over the last 2 years revenue grew +16.7 % per year. As of Nov 4, 2026.
What discount rate (WACC) does the fair value of SGIPF use?
Our models discount Sugi Holdings Co.Ltd at 8.5 %: a base by market capitalisation (mid), damped by beta 0.29, country premium for USA. The same rate applies in all 26 models.
What is a reverse DCF?
A reverse DCF turns the usual calculation around. Instead of deriving a value from assumptions, it takes today's price as given and asks: what free-cash-flow growth would a company have to deliver for exactly this price to be fair? The result is not a forecast but the expectation already priced in. For Sugi Holdings Co.Ltd that is -24.8 % per year a year over ten years, using the same discount rate (8.5 %) and the same formula as our fair value.
How much growth has Sugi Holdings Co.Ltd (SGIPF) delivered so far?
Over the past 2 years revenue at Sugi Holdings Co.Ltd grew +16.7 % a year. The price currently implies -24.8 % per year free-cash-flow growth a year. Comparing the two shows how much confidence is in the price: if it demands more than has been delivered, the business has to accelerate for the maths to work.
How fast is the sector of Sugi Holdings Co.Ltd (SGIPF) growing?
The median revenue growth in the sector is +3.5 % a year. That is the yardstick for the growth priced into Sugi Holdings Co.Ltd (-24.8 % per year a year): it shows whether the expectation is within the usual range or beyond it.
What is the free cash flow yield of Sugi Holdings Co.Ltd (SGIPF)?
The free-cash-flow yield on the price is 27.56 %: that much free cash flow Sugi Holdings Co.Ltd produces per unit of market value. When it exceeds the discount rate of our models (8.5 %), the business already earns more than its cost of capital demands, and the price needs little additional growth.
What is the intrinsic value of Sugi Holdings Co.Ltd (SGIPF)?
Intrinsic value and fair value mean the same thing: what the business is worth on its numbers, independent of the share price. For Sugi Holdings Co.Ltd it is $18.06 per share (as of Nov 4, 2026), against a price of $8.09. It is the blended result of 26 valuation models (cash flow, earnings, asset, dividend).
Is Sugi Holdings Co.Ltd stock overvalued or undervalued in 2026?
As of Nov 4, 2026, SGIPF trades below its calculated fair value: price $8.09, fair value $18.06, a gap of about +123% (undervalued). The calculation is refreshed with each new quarterly report, so the verdict can change during the year.
Is fair value the same as the market price of SGIPF?
No. The price is what the market pays today ($8.09); the fair value is what the company's own numbers justify ($18.06). For Sugi Holdings Co.Ltd the two are $9.97 per share apart. That gap is exactly why we show both numbers side by side.
How much is Sugi Holdings Co.Ltd worth?
The market values Sugi Holdings Co.Ltd at about $3.0B (market capitalisation, as of Nov 4, 2026). Per share that is $8.09; our models calculate a fair value of $18.06 per share.
What do the bullish and bearish scenarios say about SGIPF?
Our models span a range for Sugi Holdings Co.Ltd: cautious scenario $12.64, base $18.06, optimistic $23.48 per share (as of Nov 4, 2026, price $8.09). The range comes from different growth and margin assumptions, not from analyst opinions.
What is the P/E ratio of SGIPF?
Sugi Holdings Co.Ltd trades at a price-to-earnings ratio of 15.6 (as of Nov 4, 2026). A P/E on its own says little: it compares the price with ONE year of profit, while our fair value of $18.06 is built from several models across several years. Other multiples: P/B 1.6, P/S 0.4, EV/EBITDA 5.9.
How solid is the balance sheet of Sugi Holdings Co.Ltd (SGIPF)?
Balance-sheet figures for Sugi Holdings Co.Ltd (as of Nov 4, 2026): return on equity 9.9%, debt of 0.23 per unit of equity. They feed the Quality Score of 71/100, which measures business quality independently of the share price.
How far is SGIPF from its 52-week high?
Sugi Holdings Co.Ltd trades at $8.09, about 15% below its 52-week high of $9.50 and 7% above the low of $7.55 (as of Oct 30, 2026). Distance from the high says nothing about value: that is what the fair value of $18.06 is for.
Which stocks are comparable to Sugi Holdings Co.Ltd?
From the same area (Healthcare) we also value JD Health International Inc, Alibaba Health Information Technology Limited, Yifeng Pharmacy Chain Co, DaShenLin Pharmaceutical Group, among others. Each of them has its own fair-value calculation on this site using the same models, so the comparison is like for like.
Is Sugi Holdings Co.Ltd stock attractive at the current price?
The data as of Nov 4, 2026: price $8.09, calculated fair value $18.06 (+123%), Quality Score 71/100, from 26 models. Whether that fits your horizon and risk tolerance is your call. We provide the calculation, not investment advice.
How is the fair value of SGIPF calculated?
We run Sugi Holdings Co.Ltd through 26 models from four families: discounted cash flow, earnings models, asset and balance-sheet models, and dividend models. Every model gets the same audited fundamentals; the result is the weighted average of $18.06, with the spread shown as a cautious and an optimistic scenario.
Is it still worth investing in stocks now?
The global stock market currently sits 15.0% above its aggregate fair value. Sugi Holdings Co.Ltd currently trades 55% below its own fair value, and the market average says nothing about that. An expensive market is no reason to stay out and no reason to buy everything at once: keep a broad savings plan running, buy single stocks only with money you can do without, and hold part of your money liquid while the market is high. The full picture including sectors is on is it worth investing now.
What is the share price of Sugi Holdings Co.Ltd (SGIPF)?
The closing price on Oct 30, 2026 was $8.09. Our model-based fair value is $18.06, about +123% upside (undervalued). We carry closing prices from our data provider, not a live tick.
What should I pay attention to with Sugi Holdings Co.Ltd right now?
The price is below even our cautious bear case ($12.64). The market is more pessimistic than our downside scenario. Solid quality (71/100) at a price below fair value, the discount is the argument here, not the business quality. A fairly wide model range ($12.64 to $23.48) leaves room in how you read the outcome.
Key figures of Sugi Holdings Co.Ltd
How large is the market capitalisation of Sugi Holdings Co.Ltd (SGIPF)?
The market capitalisation of Sugi Holdings Co.Ltd is $3.0B. The stock-market value of the whole company: share price times number of shares. It is what the market asks for the entire business today.
What is the P/S ratio of Sugi Holdings Co.Ltd (SGIPF)?
The price-to-sales ratio of Sugi Holdings Co.Ltd is 0.69 (P/E × margin). Price to sales: market value relative to yearly revenue. Useful when profit is thin or distorted.
What are the earnings per share of Sugi Holdings Co.Ltd (SGIPF)?
Earnings per share at Sugi Holdings Co.Ltd are $0.5200 (price ÷ EPS = P/E 15.6). Earnings per share over the last twelve months: total profit spread across every single share.
What is the dividend yield of Sugi Holdings Co.Ltd (SGIPF)?
The dividend yield of Sugi Holdings Co.Ltd is 1.4% (payout 21.3%). Yearly dividend relative to the share price. 3% pays 3 per 100 invested. Below: how much of profit is used for it.
What is the net margin of Sugi Holdings Co.Ltd (SGIPF)?
The net margin of Sugi Holdings Co.Ltd is 4.5% (fiscal year 2026). How much of every unit of revenue ends up as profit. 10% means 10 cents of profit per dollar of sales.
What is the return on equity of Sugi Holdings Co.Ltd (SGIPF)?
The return on equity (ROE) of Sugi Holdings Co.Ltd is 9.9% (last twelve months). Profit relative to shareholders' equity, how efficiently the company works with its owners' money.
What is the EBIT return on assets of Sugi Holdings Co.Ltd (SGIPF)?
On an EBIT basis the return on assets of Sugi Holdings Co.Ltd is 8.6% (avg 3y). Operating profit (EBIT) relative to everything the company owns, as a multi-year average. It describes the business model rather than one good or bad year.
What is the operating margin of Sugi Holdings Co.Ltd (SGIPF)?
The operating margin of Sugi Holdings Co.Ltd is 4.6% (last twelve months). Profit from the core business (before interest and taxes) relative to revenue.
How fast is revenue growing at Sugi Holdings Co.Ltd (SGIPF)?
Revenue at Sugi Holdings Co.Ltd is growing +6.2% versus a year earlier. How much revenue grew versus a year earlier (YoY). The 3-year average next to it puts the single year in context.
How fast are earnings growing at Sugi Holdings Co.Ltd (SGIPF)?
Earnings per share at Sugi Holdings Co.Ltd are growing −18.6% versus a year earlier. How much earnings per share grew versus a year earlier.
How much net cash does Sugi Holdings Co.Ltd (SGIPF) hold?
Sugi Holdings Co.Ltd holds more cash than debt, ¥17.2B net (fiscal year 2026). The company holds more cash than debt, a safety cushion.
Free · no account needed
Watch Sugi Holdings Co.Ltd in the live analysis
One click puts Sugi Holdings Co.Ltd on your watchlist: fair value and trend at a glance, plus comparison, the diversification check and the 27,000+ stock screener.
Broad data
Nov 4, 2026